• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.22% Nasdaq Up 0.20%

    Biogen Inc. (BIIB)

    -NasdaqGS
    275.23 Up 0.41(0.15%) 4:00PM EDT
    |After Hours : 275.80 Up 0.57 (0.21%) 4:48PM EDT
    Prev Close:274.82
    Open:272.55
    Bid:260.65 x 200
    Ask:283.68 x 100
    1y Target Est:317.43
    Beta:0.503153
    Earnings Date:Apr 19 - Apr 24 (Est.)
    Day's Range:272.34 - 276.71
    52wk Range:223.02 - 333.65
    Volume:1,133,652
    Avg Vol (3m):1,664,300
    Market Cap:59.44B
    P/E (ttm):16.26
    EPS (ttm):16.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.15%59.44B
    1 0.00%N/A
    PFEUp 0.53%203.55B
    ABTDown 0.07%77.24B

    Key Statistics

    Forward P/E (1 yr):12.31
    P/S (ttm):5.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :20.94
    Quarterly EPS Est (Mar-17) :4.99
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):2.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback